Merit Financial Group’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352M Buy
8,449,244
+471,716
+6% +$18.9M 2.15% 4
2026
Q1
$289M Buy
7,977,528
+482,948
+6% +$18.5M 2.14% 3
2025
Q4
$288M Buy
7,494,580
+470,500
+7% +$17.7M 2.31% 2
2025
Q3
$254M Buy
7,024,080
+200,508
+3% +$7M 2.34% 2
2025
Q2
$234M Buy
6,823,572
+2,068,669
+44% +$65.6M 2.61% 2
2025
Q1
$149M Buy
4,754,903
+1,052,948
+28% +$34.4M 2.23% 6
2024
Q4
$118M Buy
+3,701,955
New +$120M 2.13% 9

Other funds holding QLTY

Merit Financial Group's QLTY Position: Q2 2026 in Review

Merit Financial Group increased its GMO US Quality ETF (QLTY) stake by 5.9% in Q2 2026, buying an estimated $18.9M and bringing the position to 8,449,244 shares worth $352M. The position accounts for 2.15% of the portfolio, ranked #4.

Merit Financial Group first reported a position in QLTY in Q4 2024 and has held it in 7 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Merit Financial Group held 8,449,244 shares of GMO US Quality ETF worth $352M as of Q2 2026.
  • Merit Financial Group bought 471,716 GMO US Quality ETF shares in Q2 2026, an estimated $18.9M.
  • GMO US Quality ETF made up 2.15% of Merit Financial Group's portfolio in Q2 2026, its #4 holding.
  • Merit Financial Group first reported a position in GMO US Quality ETF in Q4 2024 and has held it in 7 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.